Citation Impact
Citing Papers
The gut microbiota and host health: a new clinical frontier
2015 Standout
From Pharmacokinetics to Pharmacogenomics: A New Approach to Tailor Immunosuppressive Therapy
2004
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome
2005
Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain
2008
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Hepatocellular carcinoma
2016 Standout
Predictive factors for early mortality following liver transplantation
2003
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
The rabbit motilin receptor: molecular characterisation and pharmacology
2003
ESPEN Guidelines on Parenteral Nutrition: Intensive care
2009 Standout
Ulcerative Colitis
2011 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
2005
Traditional Statistical Methods for Evaluating Prediction Models Are Uninformative as to Clinical Value: Towards a Decision Analytic Framework
2010
LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1
2001
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
2012
Calcineurin inhibitor‐sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity
2007
Aerobic capacity is associated with 100-day outcome after hepatic transplantation
2004
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Therapeutic drug monitoring of immunosuppressant drugs in clinical practice
2002
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Effects of Motilin and Mitemcinal (GM-611) on Gastrointestinal Contractile Activity in Rhesus Monkeys In Vivo and In Vitro
2007 StandoutNobel
Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes
2008 StandoutNobel
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Prevention and treatment of hepatitis C virus recurrence after liver transplantation
2004
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Ulcerative colitis
2012 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Use of Neoral C2 monitoring: a European consensus
2005
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Imaging diagnosis of pancreatic cancer: A state-of-the-art review
2014
MITEMCINAL (GM‐611), AN ORALLY ACTIVE MOTILIN RECEPTOR AGONIST, IMPROVES DELAYED GASTRIC EMPTYING IN A CANINE MODEL OF DIABETIC GASTROPARESIS
2008 StandoutNobel
Hemostasis and thrombosis in patients with liver disease: The ups and downs
2010
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Global burden of liver disease: 2023 update
2023 Standout
Ulcerative colitis
2016 Standout
Derivation of A Risk Index for the Prediction of Massive Blood Transfusion in Liver Transplantation
2006
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Gastrointestinal promotility drugs in the critical care setting: A systematic review of the evidence*
2002
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:
2009 Standout
ESPEN Guidelines on Enteral Nutrition: Intensive care
2006 Standout
New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine
2001
Critical care issues in patients after liver transplantation
2011
Neural and muscular receptors for motilin in the rabbit colon
2000
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption Profiling
2002
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
2011 Standout
Ghrelin: Structure and Function
2005 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Mitemcinal (GM‐611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools
2007 StandoutNobel
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus–related cirrhosis
2005
Hepatocellular carcinoma
2022 Standout
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model
2015 StandoutNobel
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin
2012
Hepatocellular Carcinoma
2019 Standout
Nonalcoholic Steatohepatitis After Liver Transplantation
2019
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences
2010
Adverse events associated with ERCP
2016 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations
2016
Current treatment of benign biliary strictures.
2013
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
The Clinical Benefits of Cyclosporine C2-Level Monitoring: A Systematic Review
2007
Blocking HCV Entry as Potential Antiviral Therapy
2012
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation
2004
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Towards a small animal model for hepatitis C
2009 StandoutNobel
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of André Roy being referenced
A Comparison of Intrathecal Morphine/Fentanyl and Patient-Controlled Analgesia with Patient-Controlled Analgesia Alone for Analgesia After Liver Resection
2006
Coagulation Defects Do Not Predict Blood Product Requirements During Liver Transplantation
2008
Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations
2005
Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics
2016
PEAK CYCLOSPORINE LEVELS (Cmax) CORRELATE WITH FREEDOM FROM LIVER GRAFT REJECTION
1999
Helical CT with CT Angiography in Assessing Periampullary Neoplasms: Identification of Vascular Invasion
2002
Independent Validation of a Model Predicting the Need for Packed Red Blood Cell Transfusion at Liver Transplantation
2009
Evaluation of Renal Function in Liver Transplant Recipients Receiving Daclizumab (Zenapax), Mycophenolate Mofetil, and a Delayed, Low-Dose Tacrolimus Regimen Vs. a Standard-Dose Tacrolimus and Mycophenolate Mofetil Regimen
2005
Lack of relationship between preoperative measures of the severity of cirrhosis and short-term survival after liver transplantation
1997
MELD Score and Blood Product Requirements During Liver Transplantation: No Link
2009
Tacrolimus as Intervention in the Treatment of Hyperlipidemia after Liver Transplant
2006
Survival rate changes with transfusion of blood products during liver transplantation
2005
147 Preliminary Results From a 187 Patient Multicenter Prospective Trial Using Metal Stents for Treatment of Benign Biliary Strictures
2012
Motilin receptors in the human antrum
2000
Anti-HCV human immunoglobulins for the prevention of graft infection in HCV-related liver transplantation, a pilot study
2002